SHIOI Tetsuo

J-GLOBAL         Last updated: Oct 7, 2014 at 02:51
SHIOI Tetsuo
Kyoto University
Hospital, Cardiovascular Medicine, Deapartment of Cardiovascular Medicine
Job title
Assistant Professor
M.D., Ph.D.

Research Areas



Cardiology, Graduate School, Division of Medicine, Kyoto University
Faculty of Medicine, Kyoto University

Published Papers

T. Shioi; A. Matsumori; S. Matsui; S. Sasayama
Life Sciences   54(1) PL11-PL16   1994   [Refereed]
Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure
A. Matsumori; T. Shioi; T. Yamada; S. Matsui; S. Sasayama
Circulation   89(3) 955-958   Mar 1994   [Refereed]
Immunomodulation: A new horizon for medical treatment of heart failure
S. Sasayama; A. Matsumori; Y. Matoba; S. Matsui; T. Yamada; T. Shioi; Y. Sato; K. Doyama; C. Kishimoto
Journal of Cardiac Failure   2(SUPPL. 1) S287-S294   1996   [Refereed]
A. Matsumori; Y. Furukawa; T. Hashimoto; K. Ono; T. Shioi; M. Okada; A. Iwasaki; R. Nishio; S. Sasayama
Biochemical and Biophysical Research Communications   221(2) 391-395   Apr 1996   [Refereed]
A. Matsumori; Y. Matoba; R. Nishio; T. Shioi; K. Ono; S. Sasayama
Biochemical and Biophysical Research Communications   222(3) 678-682   May 1996   [Refereed]


J.R. McMullen; T. Shioi; L. Zhang; O. Tarnavski; M.C. Sherwood; P.M. Kang; S. Izumo
Proceedings of the National Academy of Sciences of the United States of America   100(21) 12355-12360   2003   [Refereed]
J.R. McMullen; F. Amirahmadi; E.A. Woodcock; M. Schinke-Braun; R.D. Bouwman; K.A. Hewitt; J.P. Mollica; L. Zhang; Y. Zhang; T. Shioi; A. Buerger; S. Izumo; P.Y. Jay; G.L. Jennings
Proceedings of the National Academy of Sciences of the United States of America   104(2) 612-617   2007   [Refereed]

Books etc

Cytokines and heart failure: immunomodulating agents for the management of heart failure. (included in "New Horizons for Failing Heart Syndrome")
Matsumori A, Yamada T, Matsui S, Shioi T, Sasayama S
Springer-Verlag, Tokyo   Jan 1996   
Immunomodulating effects as new aspects of a positive inotropic agent (included in "Molecular and Cellular Mechanisms of Cardiovascular Regulation"
Sasayama S, Matsumori M, Matsui S, Shioi T, Yamada T
Springer-Verlag, Tokyo   Sep 1996   
Role of Phosphoinositide 3-kinase pathway in cardiac hypertrophy (included in "Pathophysiology of cardiovascular disease")
Shioi T, McMullen JM, Izumo S
Kluwer Academic Publishers, USA   Nov 2003   

Conference Activities & Talks

Adaptive and maladaptive pathways for cardiac hypertrophy
第66回日本循環器学会学術集会   Apr 2002   日本循環器学会
Insulin-like growth factor signaling in cardiac hypertrophy
International Society for Heart Research. The 19th annual meeting of the Japanese Section   Nov 2002   International Society for Heart Research
Mammalian Target of Rapamycin (mTOR): A New Molecular Target for Cardiac Hypertrophy
第67回日本循環器学会学術集会   Mar 2003   日本循環器学会
The mammalian Target of Rapamycin (mTOR): a new molecular target for heart failure
The International Symposium of Cardiology Frontiers: Cardiomyopathy and Heart Failure   Oct 2003   
Insulin signaling pathway in cardiac hypertrophy and failure
京都府立医科大学大学院特別講義   Sep 2005   

Research Grants & Projects

Cardiovascular Disease, Heart Failure, Aging